Back to BNP Paribas Asset Management Holding S.A. BNP Paribas Asset Management Holding S.A.

SNDXSNDX
8 quarters

Position history for BNP Paribas Asset Management Holding S.A.BNP Paribas Asset Management Holding S.A.'s holdings in SYNDAX PHARMACEUTICALS INC

BNP Paribas Asset Management Holding S.A. holds 1.8M shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $39.1M as of 2026-Q2. The position was increased (+3.3% shares). SNDX represents 0.0% of BNP Paribas Asset Management Holding S.A.'s portfolio.

Current Value

$39.1M

Current Shares

1.8M

Total Value Change

+$24M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.8M
+3.3%
$39.1M0.0%$21.86
30
2026-Q1
Increased
1.7M
+25.9%
$40.5M0.0%$21.40
36
2025-Q4
Increased
1.4M
+11.3%
$28.9M0.0%$20.74
32
2025-Q3
Decreased
1.2M
-14.5%
$19M0.0%$15.56
0
2025-Q2
Increased
1.4M
+18.4%
$13.5M0.0%$9.04
33
2025-Q1
Increased
1.2M
+19.4%
$15M0.0%$13.18
33
2024-Q4
Increased
1M
+29.8%
$13.5M0.0%$12.52
35
2024-Q3
New
787,785
-
$15.2M0.0%$18.89
39

Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used